Chav Haujlwm Thoob Ntiaj Teb

Thaum Lub Kaum Ob Hlis 3, 2024, cov tshuaj tshiab Zepzelca (lurbinectedin rau kev txhaj tshuaj) tau txais kev pom zoo rau kev lag luam los ntawm Tuam Tshoj Lub Chaw Haujlwm Saib Xyuas Khoom Siv Kho Mob Hauv Tebchaws (NMPA) los ntawm qhov kev tshuaj xyuas tseem ceeb. Cov tshuaj no yog qhia rau kev kho mob rau cov neeg laus uas muaj mob qog nqaij hlav me me hauv lub ntsws ...Nyeem ntxiv»

Thaum Lub Kaum Ob Hlis 31, Tuam Tshoj Lub Chaw Tswj Xyuas Khoom Siv Kho Mob Hauv Tebchaws (NMPA) tau pom zoo VYLOYTM (zolbetuximab), ua ke nrog fluoropyrimidine- thiab platinum-muaj chemotherapy, rau thawj kab kev kho mob ntawm cov neeg mob uas muaj kev loj hlob ntawm tib neeg epidermal uas tsis tuaj yeem phais lossis metastatic hauv zos ...Nyeem ntxiv»

Thaum Lub Kaum Ob Hlis 31, 2024, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (tus "Tuam Txhab") tau txais kev tso cai ua lag luam hauv Suav teb los ntawm National Medical Products Administration (NMPA) rau cov tshuaj monoclonal antibody ("mAb") uas tau tsim los ntawm programmed cell death ligand1 (PD-L1) tagitanlim...Nyeem ntxiv»

C-CAR031 yog ib qho kev kho mob autologous, armored GPC3-targeting chimeric antigen receptor T-Cell (CAR-T), uas tau kawm txog kev kho mob HCC. Nws yog raws li ib qho tshiab GPC3-targeting CAR-T tsim los ntawm AstraZeneca siv lawv cov dominant negative transforming growth factor-beta receptor II dominant negati...Nyeem ntxiv»

Thaum Lub Kaum Ob Hlis 20, 2024, Tuam Tshoj Lub Chaw Saib Xyuas Khoom Siv Kho Mob Hauv Tebchaws (NMPA) tau pom zoo Daim Ntawv Thov Tshuaj Tshiab (NDA) ntawm DOVBLERON ® (taletrectinib adipate capsule), ib tiam tom ntej ROS1 tyrosine kinase inhibitor (TKI), rau kev kho mob rau cov neeg laus uas muaj ROS hauv zos lossis metastatic ...Nyeem ntxiv»

C-CAR031 yog kev kho mob autologous, armored GPC3-targeting chimeric antigen receptor T-Cell (CAR-T), uas tau kawm txog kev kho mob HCC. Kev tshawb fawb txog kev nce qib ntawm C-CAR031 hauv hepatocellular carcinoma (HCC) tau nthuav tawm hauv kev sib tham txhua xyoo ntawm American Society of Clinical Oncology (ASCO) h...Nyeem ntxiv»

GT101 yog kev kho mob hlwb autologous uas ua los ntawm TIL uas tau nthuav dav thiab rov ua dua tshiab los ntawm tus neeg mob tus kheej lub qog. Kev kho mob yog ua los ntawm kev sau cov nqaij mob qog los ntawm cov neeg mob thiab rho tawm TIL. Cov TIL uas tau rho tawm yuav raug nthuav dav siv Grit Bio lub platform tsim khoom tshwj xeeb StemTe...Nyeem ntxiv»

Cov hlwb TAEST16001 yog cov hlwb T autologous uas tau tsim los ntawm kev hloov pauv caj ces uas qhia txog NY-ESO-1-specific T-cell receptor (TCR) uas tsom mus rau NY-ESO-1 (qhia tawm hauv ntau hom qog nqaij hlav) cov nqaij mos mos sarcoma (STS) hauv cov ntsiab lus ntawm HLA-A*02:01. Ib txoj kev tshawb fawb theem I ntawm cov neeg mob uas muaj S siab heev ...Nyeem ntxiv»

Thaum Lub Kaum Ob Hlis 04, 2024, Daim Ntawv Thov Tshuaj Tshiab (NDA) rau kev sib xyaw ua ke ntawm TYVYT® (sintilimab txhaj tshuaj) thiab ELUNATE® (fruquintinib) tau txais kev pom zoo hauv Suav teb rau kev kho mob ntawm cov neeg mob uas muaj mob qog nqaij hlav endometrial siab heev nrog Mismatch Repair proficient (pMMR) qog uas tau ...Nyeem ntxiv»

GC203 yog ib txoj kev kho mob TIL tshiab uas tsis yog kab mob uas hloov kho los ntawm cov noob caj noob ces uas tau tsim los ntawm kev siv Juncell Therapeutics lub platform nthuav dav DeepTIL® thiab NovaGMP® gene modification platform. DeepTIL® ua rau TILs muaj zog txaus uas tsis tas yuav muaj kev sib xyaw ua ke IL-2 tom qab kev txhaj tshuaj, ib qho...Nyeem ntxiv»

Glioblastoma Multiforme (GBM) yog ib qho ntawm cov mob qog nqaij hlav uas ua rau tuag taus tshaj plaws, thiab yuav luag txhua tus neeg mob rov qab mob dua raws li tus qauv kev kho mob tam sim no rau GBM uas nyuam qhuav kuaj pom. GBM uas rov qab mob dua (rGBM) qhia txog qhov nruab nrab ntawm kev ciaj sia tsawg dua 8 lub hlis nrog rau cov kev xaiv kho mob tsawg. TX103 yog CAR-T ce...Nyeem ntxiv»

RD13-02 yog ib yam khoom siv CAR-T cell uas siv tau rau txhua tus neeg uas tsom mus rau CD7 uas tau los ntawm cov neeg pub dawb uas noj qab nyob zoo, thiab yog siv rau kev kho mob ntawm cov T-cell uas rov qab mob lossis tsis kho tau (T-ALL/LBL). Nws yog hloov kho caj ces kom tsis txhob muaj kev tua tus kheej, kab mob graft-versus-host (GvHD), thiab kab mob host-versus-...Nyeem ntxiv»